Exciting insights from our #AACR24 presentation! Our latest studies confirm that our Decoy technology activates not just the innate but also the adaptive immune system. Plus, promising synergies with IL-2 could enhance combination therapies. Dive into the full discussion!
$INDP…

Are cancer vaccines ready for prime time? Highlights from our Johns Hopkins Kimmel Cancer Center study of an off-the-shelf mutant KRAS vaccine in individuals at high risk of developing pancreatic cancer are featured here #AACR24
cancertodaymag.org/cancer-talk/va…

In this interview from #AACR24 , Shawn Levy from Element Biosciences talks about #AVITI24 , their new multiomics platform that can provide deeper insights into cancer biology.
biotechniques.com/molecular-biol…

Congratulations to Dr. Lindsay LaFave on receiving the AACR Career Development Award in Lung Cancer Research! 🎊 This award will support research efforts to identify new therapeutic rationales in #LungCancer . Albert Einstein College of Medicine - Official #MECCC #MonteProud #AACR24

Our cofounders chatted with San Diego Business Journal about our recent #AACR24 data showing our lead drug candidate works across many #cancer types to kill tumor cells but leave healthy cells alone – as well as how our upcoming #clinicaltrial could quickly yield data.

sdbj.com/life-sciences/…

After two years of participating in the AACR Scientist Survivor program this year I got to mentor a group along side the amazing scientific mentor Jerry SH Lee - Allison Rosen, MS
Bayer Oncology Medical

#AACR24 #Cancer #Cancer Research #OncoDaily #Oncology #Mentorship

oncodaily.com/54779.html

Join us in celebrating #NationalCancerResearchMonth this May! 🔬

RutgersCancerInstNJ with RWJBarnabas is dedicated to advancing #cancerresearch and providing state-of-the-art care for patients.

cinj.org/research/natio…

#AACR24 #cancercare Robert Wood Johnson University Hospital AACR

#AACR24 was a whirlwind of exciting breakthroughs like activating the immune system to fight cancer through #Immunotherapy

Advancements like these play a crucial role in offering patients a fighting chance. Explore our approach in #oncology : curadev.in/immune-oncology

Missed this year’s #AACR24 meeting? Visit the #Arvinas #Medical congress site to learn more about preclinical data from our #PROTAC BCL6 degrader for #non -Hodgkin #lymphoma

Click here to learn more: bit.ly/3t3wQaq

April is just about over - what a month! It was so exciting to hear all the positive words about the special issue of Cancer Discovery at #AACR24 ! Don't miss all the special commentaries, Hallmarks of Precancer, and MUCH more - what was your favorite? aacrjournals.org/cancerdiscover…

Throwback to earlier this month: Simon Gregory presenting our work on the Akoya Biosciences platform, studying the spatial biology of #gliomas at #AACR24 ! 🧠💻🧬

#CancerResearchSavesLives #spatialbiology

Incredibly grateful to AACR for the support! Enjoyed connecting with other awardees and colleagues at the AACR Grants Award Reception at #AACR24 . #MECCC

RMC-5127, a First-in-Class, Orally Bioavailable RAS(ON) G12V-Selective Tri-Complex Inhibitor,
is CNS-Penetrant and Drives Regressions in Intracranially Implanted #KRAS G12V Xenograft Tumors
#AACR24 🎯

Sundar Jagannath, MBBS, discusses linvoseltamab and expands on key efficacy and safety findings from the LINKER-MM1 trial in patients with relapsed/refractory multiple myeloma. The Tisch Cancer Institute #mmsm #oncology #MedTwitter #AACR24 onclive.com/view/decreasin…

Unlock the potential of #ExtracellularVesicles (EVs) #Proteomics for non-invasive cancer monitoring! Delve into our #AACR24 collaboration with Nexosome Oncology, where our #TrueDiscovery ® services revealed cancer-specific biomarkers in EVs.
More: ow.ly/23mf50RsknU

Read a recap of 'AI at the Interface' at AACR 2024 plenary session in AACR Annual Meeting News - Vivek Subbiah, MD
Sarah Cannon Docs Anant Madabhushi Thomas Clozel Mia Levy, MD, PhD

#AACR24 #Cancer #Cancer Research #ClinicalTrial #OncoDaily #Oncology

oncodaily.com/54750.html

Mural Oncology’s Joshua Heiber & Mark Whitmore presented at the AACR Annual Meeting this month. Read their takeaways & learn more about the pre-clinical data from our interleukin-18 (IL-18) and IL-12 programs that were shared for the first time: bit.ly/4daBbLF

#AACR24

Kelly K. Hunt, MD, on Breast Cancer and Neoadjuvant Therapy: Expert Commentary ascopost.com/videos/aacr-an… #bcsm #breastcancer #oncology #AACR24 AACR Kelly K Hunt MD Anderson Cancer Center

Patient advocates at the recent AACR Annual Meeting in San Diego were connected with informative sessions, expert mentors, and a chance to share their knowledge through the AACR Scientist↔Survivor Program®. bit.ly/4b7HNsd #AACR24

Spring is here which means conference season in is full swing! While we prep for ASCO, we wanted to make sure you didn't miss our exciting data from #AACR24 . Check out and download our Late Breaking Abstract and posters: hubs.ly/Q02vbKn20
#ASCO24